Alzheimer’s disease research sheds new light on medication side effects

December 15, 2022

A new study led by Western Sydney University has shed new light on the treatment of Alzheimer’s disease, after researchers identified proteins causing neuronal allergy in neurons treated with Alzheimer therapeutic antibodies.

Q&A: Canada slowest in reporting bird flu at 618 days—but past COVID response shows potential for improvement
The global average for countries to report genetic information about bird flu, crucial to tracking and preventing a human pandemic, was seven months, and Canada came in last, a new study has found.
Cancer researchers identify the 'switch' that allows intestinal cells to regenerate after injury
Researchers from the University of Colorado Cancer Center have solved a cellular mystery that may lead to better therapies for colorectal and other types of cancer.
Neutrophils' mitochondrial sensing disrupted in lupus patients, study finds
Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect infection and how that fails to happen in people with lupus.
Fusing two immune system proteins leads to a new method of generating antibodies
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to advance research projects.
Meniscus injuries may soon be treated by customizable hydrogel
Meniscus tears are common knee injuries that have long frustrated patients and doctors due to limited repair options. A new 3D-printed hydrogel made from cow meniscus could transform how these injuries heal, according to results of a pre-clinical study published in Bioactive Materials from researchers in the Perelman School of Medicine at the University of Pennsylvania.

Alzheimer’s disease research sheds new light on medication side effects

Recent Posts

JUST IN